Sanofi Settles Thousands of Zantac Cancer Lawsuits in US

Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, without disclosing the financial terms. The settlement, which still needs to be finalized, will resolve most of the lawsuits against the French pharmaceutical company in U.S. state courts, except for Delaware. Sanofi did not admit any liability in the settlement and stated that it is settling to avoid the expense and ongoing distraction of the litigation. The company still faces about 20,000 lawsuits over Zantac in Delaware state court, and a judge is considering the fate of approximately 70,000 cases filed against Sanofi and other defendants.